Clinical trial
Acute and Chronic Effects of Tefillin Use on Remote Cardiac Ischemic Preconditioning
NCT06390358 is registered in ClinicalTrials.gov with Jack Rubinstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute and Chronic Effects of Tefillin Use on Remote Cardiac Ischemic Preconditioning
- Lead sponsor
- Jack Rubinstein
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 1, 2024
- Completion date
- May 1, 2025
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac function and preconditioning